🍪 Cookies
We use analytics cookies (Google Analytics) to understand how you use the site. You can accept or reject them — the site works fully either way.
Percepta® is a patent-protected brain health natural dietary supplement (active ingredients, PTI-00703® Cat’s claw and MemorTea® - a specific oolong tea extract). Cerebrum DAO will be supporting the development of near- and long-term solutions for targeting cognitive decline, memory loss and neurodegenerative diseases. The global market for brain health supplements is over $8.6b - most if not all lack clinical evidence to support efficacy. Percepta® has robust patent protection and highly promising research results. Percepta has the potential to be the category leader in this fast growing $8.6b market with human evidence to support outcomes and the funding of future studies that could lead to FDA botanical drug status which is the ultimate goal. This IP-NFT represents a world’s first tokenization of a robust patent portfolio and a world’s first tokenized crowdsale for a clinical evidence study. Success with this study can lead to future trials that create the potential for FDA botanica
IP Tokens of IPNFT #129 (CLAW) is a cryptocurrency that can be traded on various exchanges. It has a current market capitalization of $120,654, making it one of the notable digital assets in the crypto market.
The current price of IP Tokens of IPNFT #129 (CLAW) is $0.1097. Prices update in real-time based on market activity across major cryptocurrency exchanges.
You can buy IP Tokens of IPNFT #129 (CLAW) on major cryptocurrency exchanges such as Binance, Coinbase, and Kraken. Always use a reputable exchange and enable two-factor authentication to secure your account.
Whether IP Tokens of IPNFT #129 is a good investment depends on your financial goals, risk tolerance, and research. Cryptocurrency markets are highly volatile. Always do your own research and consider consulting a financial advisor before investing.
Top cryptocurrencies with market capitalization closest to this coin.